Navigation Links
EU awards $4 million for pneumonia research
Date:5/11/2009

Pneumonia infections are not only a problem of developing countries. In Germany more than 60,000 people die annually due to this disease, which is mostly caused by the bacterial species Streptococcus pneumoniae. Combating pneumococcal infections is getting more and more difficult and current vaccines mediate only partial protection.

13 international research institutions representing 10 countries in Asia, Europe and South America have joined forces with the aim to develop new antibiotics and vaccines to fight pneumococcal infection. The department of Microbial Pathogenicity of the Helmholtz Centre for Infection Research (HZI) in Braunschweig is coordinator of the project named "CAREPNEUMO", which is running for three years and funded with 3 Million Euro by EU.

Antibiotic resistant bacterial pathogens are a serious problem: many drugs which successfully eliminated an infection in the past have become ineffective. The emergence of multiresistant bacteria is a severe problem and a variety of antibiotics are now ineffective. Singh Chhatwal, head of the department "Microbial Pathogenicity" at the HZI: "In France and Spain, about half of the pneumococcal isolates are resistant against at least one antibiotic".

The two currently available pneumococcal vaccines have the disadvantage that not all of the more than 90 pneumococcal subspecies, named serotypes, are covered. Prof. Singh Chhatwal said "while vaccination reduces spreading of these seven serotypes it has unfortunately led to appearance of uncommon pneumococcal serotypes. In addition, in Germany and United States for example, the prevalent serotypes are different to those serotypes commonly found in India, which complicates worldwide treatment and prevention strategies. "Therefore, we have to find alternatives for treatment and prevention of pneumococcal infections", says Singh Chhatwal. For this reason, he has initiated the research consortium CAREPNEUMO.

The objectives of the consortium is divided into three research projects: At first, scientists want to identify and characterize pneumococcal serotypes, which are of main importance worldwide. Afterwards, pneumococcal escape of human immune system and induction of pneumonia will be investigated. Then, based on the acquired knowledge, new therapies, antibiotics and vaccines will be developed.


'/>"/>

Contact: Dr. Bastian Dornbach
bad@helmholtz-hzi.de
49-053-161-811-407
Helmholtz Association of German Research Centres
Source:Eurekalert

Related medicine news :

1. Corbett Selected to Host the Only Midwest Global Awards Judging Competition
2. Good Clinical Practice Journal Awards: Winners Announced
3. NIH awards $10.8M to Columbia to study connection between diabetes and heart disease
4. NIH awards Einstein multimillion dollar grant to extend studies of exceptional longevity
5. 2007 EURYI: 20 researchers to receive Nobel Prize-sized awards in Helsinki
6. HRET Awards Four Health Career Scholarships
7. Portico Systems Wins Three Awards in 30 Days
8. Kensey Nash Reports Acceleration of Stock Awards Triggered by Shareholder Acquisition of Greater Than 20% of Outstanding Shares
9. Bioniche Food Safety Vaccine Receives Global Top Honours in Industry Excellence Awards
10. The Sisters of Charity Health System Awards Four Nursing Scholarships in Ohio and South Carolina
11. U.S. Labor Department Awards $10.1 Million for Safety and Health Training Grants
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/3/2016)... ... May 03, 2016 , ... Registration is now open for the 31st annual AIDS Walk ... Hatch Memorial Shell on the Esplanade. The event regularly draws thousands of participants, making it ... competitive, timed event fully sanctioned by the USA Track & Field Association. , The ...
(Date:5/3/2016)... ... 2016 , ... Elizabeth Murray has always loved walking one to two miles ... her shoulder and one on her arm. But she got to the point where ... valve prolapse. , The valves of the heart wouldn’t close properly resulting in mitral ...
(Date:5/3/2016)... ... 03, 2016 , ... Empyrean Benefit Solutions, Inc., the Hi-Touch ... center in La Vergne, Tennessee, near Nashville. The new center will complement Empyrean’s ... client services. , “Our Nashville-area center allows us to achieve several goals,” said ...
(Date:5/3/2016)... ... 03, 2016 , ... Ogawa World USA introduced the first of its kind ... exclusive Smart Application. The Smart 3D combines the best in technological advancement, design, and ... profile and specialized massage program, each user has a tailored experience unparalleled by any ...
(Date:5/3/2016)... ... May 03, 2016 , ... Dr. Poneh Ghasri, cosmetic dentist in ... both new and existing patients. Cosmetic dentistry allows patients to improve the aesthetics of ... smiles with some minor or more serious cosmetic flaws. These specials allow patients to ...
Breaking Medicine News(10 mins):
(Date:4/28/2016)... FLINT, Mich. , April 28, 2016 /PRNewswire/ ... transaction . Diplomat Pharmacy, Inc. (NYSE: DPLO), the ... it has signed a definitive agreement to acquire ... Advanced Specialty Pharmacy ("TNH"), a leading specialty pharmacy ... Van Nuys, California . In 2015, ...
(Date:4/28/2016)... Dr. ... und Stephen Schmidt werden Teil ... ein führender Anbieter cloudbasierter Softwarelösungen für den ... neue Führungskräfte zum Team Sicherheit und Pharmakovigilanz ... Erfahrungen mitbringen.  Dies wird die Geschäftseinheit Sicherheit ...
(Date:4/28/2016)... Dr. Vivek Ahuja , George ... phen Schmidt Join the Growing Organization ... for life sciences, today announced key new leaders have joined the ... a growing business.  This will bolster the company,s safety business unit ... ArisGlobal in the position of Vice President - Safety. George has ...
Breaking Medicine Technology: